Progesterone-Receptor Negative Breast Cancer is related to bartholin's gland adenoma and uterine corpus adenosarcoma. An important gene associated with Progesterone-Receptor Negative Breast Cancer is ESR1 (Estrogen Receptor 1), and among its related pathways/superpathways are Breast cancer pathway and Signaling by ERBB4. The drugs Progesterone and Gemcitabine have been mentioned in the context of this disorder. Affiliated tissues include breast and lymph node.